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A protective effect of intravenous diltiazem pretreatment
on transmural histologic damage in ischemic hearts of
30 pigs was determined morphometrically. The pig hearts
were rendered ischemic by ligation of the distal left an-
terior descending coronary artery for 20, 40 and 120
minutes in separate experiments. Heart rate, left ven-
tricular systolic pressure and systemic diastolic pressure
decreased slightly during 40 minutes of occlusion, and
then recovered to control levels. However, there were
no significant differences between control and diltiazem·
treated groups. Blood flow, measured by the micro-
sphere technique, was uniformly absent in the ischemic
areas in both control and diltiazem-treated hearts. In
the few cell layers immediately beneath the endocardium
and epicardium, little cellular damage was observed in
either group regardless of the duration of ischemia. In
Diltiazem belongs to a group of calcium antagonists also
known as calcium channel or calcium entry inhibitors (1-5).
It is a potent coronary vasodilator and appears to have direct
protective effects on ischemic hearts (4,6,7). Clinically, it
is used frequently in the treatment of angina pectoris (8-11 l.
It is thought that the calcium antagonists, nifedipine ( 12l,
verapamil (13) and diltiazem (7,14), reduce ischemic myo-
cardial damage in dog hearts, which possess rich collateral
circulation. However, in the baboon heart with only minimal
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the subendocardial, mid-myocardial and subepicardial
layers, less cellular damage was detected after all periods
of ischemia in hearts exposed to diltiazem in comparison
with that observed in control hearts. However, even in
the drug-treated hearts, after 2 hours of occlusion, the
cells remained severely injured.
The protective effect of diltiazem on the cellular in-
tegrity in the ischemic myocardial regions appears to be
independent of blood flow and may be a reflection of a
direct effect of diltiazem on myocytes. The precise mech-
anism is unresolved. Nevertheless, in the ischemic heart
without a significant collateral circulation, pretreatment
with the calcium channel blocking drug, diltiazem, re-
sults in a delayed onset of cellular damage after acute
coronary artery ligation and less cellular damage at isch-
emic periods up to 40 minutes' duration.
collateral circulation, Geary et al. (15) recently reported a
failure of nifedipine therapy to reduce myocardial infarct
size, but acute ischemic cellular damage was not evaluated
directly.
In a recent report from this laboratory (161 using light
and electron microscopy, we identified specific transmural
histologic damage, after 2 hours of acute ischemia, in the
left ventricular wall of pig hearts where the native collateral
circulation is very poor or absent entirely. The tissue im-
mediately beneath the endocardium and epicardium (to a
depth of 10 cells) showed only mild ischemic-induced dam-
age regardless of the period of ischemia, while the intra-
mural regions developed progressive cellular damage in pro-
portion to the duration of ischemia. In these intramural
areas, a transmural damage gradient from the subendocar-
dium to the epicardium existed at ischemic periods of less
than I hour.
Accordingly, the purpose of the present study was to
determine if pretreatment with the calcium channel blocking
drug, diltiazem, protects against the progression of trans-
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mural cellular damage in the porcine left ventricular wall
during the first 2 hours of ischemia. The pig heart is a
particularly useful model of ischemia that, because of its
few native collateral vessels, probably resembles the myo-
cardial ischemia that may occur in the human heart which
lacks collateral circulation. This model further gives us the
opportunity to test our hypothesis that the calcium channel
inhibitor diltiazem protects the jeopardized myocardium in
a no-flow environment, which would be evidence of a direct,
blood flow-independent, protective effect.
Methods
Experimental preparation. Thirty farm pigs weighing
20 to 30 kg were used in this study. Fifteen pigs were
pretreated with diltiazem before coronary artery occlusion
and the other 15 were used as control animals. The pigs
were separated into three groups of five animals each, ac-
cording to periods of coronary artery occlusion of 20, 40
and 120 minutes.
They were sedated with ketamine (2 mg/kg body weight),
anesthetized with sodium thiamylal (10 mg/kg intrave-
nously) and maintained throughout the experimental pro-
cedures on pentobarbital sodium (25 mg/kg). No antiar-
rhythmic agents were given during the experiments.
Instrumentation. Tygon catheters (formulation S-54-HL,
0.040 inch [0.10 cm] inner diameter x 0.070 inch [0.178
cm] outer diameter, and 0.050 inch [0.127 cm] inner di-
ameter x 0.090 inch [0.229 cm] outer diameter, U.S. Stone-
ware) were inserted in the femoral vein and artery, respec-
tively, with the tips located at the level of the diaphragm.
The heart was exposed through a median sternotomy and
suspended in a pericardial cradle. A Tygon catheter was
inserted into the left atrium. A solid state pressure transducer
catheter (Millar Instruments, model P-1350) was inserted
in the left ventricle through an apical stab wound and secured
by a pursestring suture. Simultaneous and continuous re-
cording of arterial (Statham model P23Db) and left ven-
tricular pressures and lead II of the electrocardiogram were
made on a rectilinear oscillograph (Brush Gould, model
2800).
Study protocol. Thirty minutes after completion of in-
strumentation, baseline hemodynamic variables were col-
lected and recorded. Diltiazem (20 j.tg/kg per min) was
infused through the femoral vein catheter for 20 minutes.
Then the distal one-third of the left anterior descending
coronary artery was completely ligated using a Vesseloops
(Med General) rubber band. Diltiazem infusion was stopped
for the duration of ischemia. The dose of the drug selected
was consistent with the approximate clinical doses used to
achieve a therapeutic level (17) and that used in previous
experimental studies (7,14,18).
BLood flow distribution was quantitativeLy determined by
the radionuclide-Iabeled microsphere technique (19,20). Two
million 15 j.t microspheres, labeled with either cerium-141,
ruthenium-I03 or niobium-95, were injected into the left
atrium over a period of 20 seconds, while a simultaneous
timed reference blood sample was collected through the
implanted arterial catheter over 3 minutes, beginning 15
seconds before the isotope injection. The first isotope label
was injected at 5 minutes before infusion of diltiazem and
the second microsphere injection was made during diltiazem
infusion, immediately before coronary occlusion. The third
was injected 5 minutes before the end of the occlusion
period. Patent blue violet dye (21) was injected into the left
atrium at the end of the occlusion period to provide a qual-
itative anatomic indicator of the perfusion region (blue) as
distinguished from the ischemic region (unstained). Hearts
Figure 1. The tissue sampling procedure is
shown diagrammatically (modified from Fu-
jiwara et al. [16], by permission of the Amer-
ican Heart Association, Inc.). LA = left
atrium; LAD = left anterior descending
coronary artery; LeX = left circumflex
coronary artery; LV = left ventricle; RV =
right ventricle.
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Table 1. Classification of Myocardial Cellular Damage
Grade Characteristics
A. Light Microscopy
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Grade 0
Major
Minor
Grade I
Major
Minor
Grade 2
Major
Minor
Grade 3
Major
Minor
Grade 4
Major
Minor
Grade 5
Major
Minor
Grade 0
Grape I
Grade 2
Grade 3
Grade 4
Grade 5
No clumping or margination of nuclear chromatin
Compact intermyofibrillar and perinuclear substances, compact myofibril with regular Z bands, no vacuolization or granulation of
cytoplasm
Minimal clumping and margination of chromatin
Decreased staining of intermyofibrillar and perinuclear substances
Mild clumping and margination of chromatin
Markedly decreased staining of intermyofibrillar and perinuclear substances: occasional vacuolization in cytoplasm
Moderate clumping and margination of chromatin
No staining of intermyofibrillar and perinuclear substances, occasional vacuolization in cytoplasm
Marked clumping and margination of chromatin
Occasional granulation and increased vacuolization
Markedly clumped and marginated nuclear chromatin with obscure nuclear membranes
Increased granulation and vacuolization in cytoplasm, disappearance of architecture in cytoplasm
B. Electron Microscopy
Abundant glycogen, intact mitochondria, no nuclear change
Minimal clumping and margination of chromatin, mild decrease in the amount of glycogen, minimal change of mitochondria
Mild clumping and margination of chromatin, markedly reduced glycogen. mitochondria with mild swelling and relatively clear matrix
Moderate clumping and margination of chromatin, sparse glycogen, mild intermyofibrillar edema and mitochondria with moderate
swelling, abnormally clear matrices, appearance of dense amorphous granules
Marked clumping and margination of chromatin, disruption of myofibril with wide I bands. increased myofibrillar edema. increased dense
mitochondrial granules, abnormally clear matrices and marked swelling in mitochondria. occasional loss of cristae and sparse glycogen.
early signs of sarcolemmal disruption
Markedly clumped and marginated nuclear chrl)matin with obscure nuclear membrane, myofibril with increased breakdown at the Z band
and intercalated disc, marked and abnormally clear intermyofibrillar space. marked swelling of mitochondria, loss of cristae, abundant
dense mitochondrial granules, increased disruption of sarcolemma. absence of glycogen
were excised immediately after injection of patent blue vi-
olet dye, The diltiazem concentration was measured in ve-
nous blood in one study group immediately before occlusion
and after 40 minutes of occlusion. Blood diltiazem concen-
trations were determined by Marion Laboratories (Kansas
City, Missouri) (22).
Hearts were placed in cold phosphate buffer solution and
were sliced in I cm serial sections in a plane parallel to the
atrioventricular groove, The ischemic area was clearly de-
marcated by the absence of dye, Tissue samples for histo-
logic study and measurement of regional blood flow were
taken from the center of the ischemic area in the anteroseptal
left ventricular wall (no visible dye) and from the normally
perfused posterior left ventricular wall (intense dye), Tissues
in which regional blood flow was determined were first fixed
in 10% formalin and then divided into the inner, middle
and outer thirds in ischemic and nonischemic regions. Each
sample weighed at least 400 mg and contained a minimum
of 100 microspheres in normal tissues. Differential spec-
trometry was performed on each sample in a gamma well
counter (Packard, model A-5980) with nuclide specific win-
dows. Regional blood flows were calculated on a unit weight
basis by multiple simultaneous equation solutions using a
PDP-I 1103 digital computer program.
Sampling for transmural histologic study was done ac-
cording to the procedure reported previously (16). Briefly,
transmural tissues from the center of ischemic and nonisch-
emic areas were divided into the inner, middle and outer
thirds (approximately 2.0 x 3.0 x 1.0 mm). Each section
was fixed for 2 hours in cold 2.5% glutaraldehyde made in
0.2 M phosphate buffer with an osmolarity of 320 mOsm/kg,
pH 7.4. All were post-fixed for 2 hours in I% osmium
tetroxide. dehydrated in graded series of ethanol and pro-
pylene oxide and embedded in the Spurr medium.
Thick sections (I p.,) from each specimen block were cut
in a direction parallel with the myocardial fibers with an
MTB2 ultramicrotome and were stained with toluidine blue
for light microscopic study.
Morphometric analysis of the thick sections was done
using a point counting technique at a magnification of 400
(23). A total of 12 blocks, 4 each from inner, middle and
outer thirds from each heart, were evaluated. To exclude
the artifact that accompanies immersion fixation, histologic
examination in ischemic tissue and quantitation of trans-
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Table 2. Hemodynamic Data
Heart rate (beats/min)
DTZ
Control
LVSP (mm Hg)
DTZ
Control
LVEDP (mm Hg)
DTZ
Control
Aortic DP (mm Hg)
DTZ
Control
Infusion of
Diltiazem
o Min
110 ± II
(n = IS)
112 ± 19
(n = IS)
93 ± 16
92 ± II
2 ±
I±
66 ± 17
58 ± 8
20 Min
98 ± 10*
(n = 15)
81 ± 15*
2 ± 2
52 ± 15*
Occlusion of Distal Left Anterior
Descending Coronary Artery
10 Min 20 Min 40 Min 120 Min
100 ± 9* 100 ± 11* 106 ± 14 112 ± 14
(n = 15) (n = 15) (n = 10) (n = 5)
112 ± 19 113 ± 20 107 ± 19 108 ± 17
(n = 15) (n = IS) (n = 10) (n = 5)
86 ± 14* 87 ± 16* 92± 18 93 ± 27
91 ± 15 90 ± 10 90 ± 14 90 ± 7
2 ± I 2 ± 2 2 ± 2 2 ±
2 ± 2 2 ± 3 I ± I I±
58 ± 15* 58 ± 16* 61 ± 18* 64 ± 24
60 ± 7 59 ± 10 56 ± 5 59 ± 5
*p < 0.05 in paired t test. Data are shown as mean values ± standard deviation. Aortic DP = aortic diastolic pressure; DTZ = diltiazem, 20 J,tg/kg
per min, for 20 minutes before coronary occlusion; LVEDP = left ventricular end-diastolic pressure; LVSP = left ventricular systolic pressure.
mural cellular damage were restricted to a 0.1 or 0.2 mm
layer at the surface of each tissue sample (Fig. I). Because
nuclear changes are among the most sensitive cellular in-
dicators of ischemia, analysis of transmural cellular mor-
phology was made only in cell sections that contained a
nucleus. The histologic sections were graded independently
by two experienced morphologists (H.F. and M.A.) without
knowledge of duration of ischemia and transmural location
from which the sample derived. The two graders assigned
the same scores to 95% of the samples, and differed by one
grade in 3% of samples and by two grades in 2% of samples.
The total average variability of all sample scores was ±
0.3 units between both graders. The conclusions drawn from
the data obtained by either observer were not different. In
layers II, III and IV, 80 to 100 cells in each block were
graded. Fifteen to 20 cells were graded in each of the narrow
epicardial (V) and endocardial (I) layers. The mean values
of cell damage grades were calculated for each sample and
averaged for all hearts. Two representative blocks from
inner, middle and outer thirds were thin-sectioned (0.06 f.L)
for electron microscopy. Thin sections were mounted on
plain copper grids and stained with uranyl acetate and lead
citrate and examined in a Philips 300 transmission electron
microscope.
The ischemic cellular damage was graded from 0 (nor-
mal) to 5 (most severe) with light microscopy and was
confirmed by electron microscopy, as previously reported
in detail (16). The microscopic criteria for the quantitative
estimation of cell damage are summarized in Table 1. Elec-
tron microscopy allowed an examination of the ultrastruc-
tural features of the cellular injury graded by light micros-
copy. For example, various degrees of nuclear chromatin
changes (margination) that were easily recognizable in the
light microscopy may affect other cellular organelles. The
Table 3. Effect of Diltiazem on Regional Blood Flow (mllg per min) After Occlusion of Coronary Artery
Inner third
Control
DTZ
Middle third
Control
DTZ
Outer third
Control
DTZ
Baseline
1.05 ± 0.24
(n = 15)
0.94 ± 0.28
(n = 13)
0.97 ± 0.34
0.89 ± 0.21
1.03 ± 0.46
1.04 ± 0.33
Immediately After
Infusion of DTZ
1.70 ± 0.59*
(n = 13)
1.57 ± 0.71*
1.47 ± 0.61 *
After Occlusion
20 Min 40 Min 120 Min
0.02 ± 0.01 0.01 ± 0.01 0.00 ± 0.01
(n = 5) (n = 5) (n = 5)
0.00 ± 0.00 0.01 ± 0.02 0.00 ± 0.00
(n = 4) (n = 5) (n = 4)
0.01 ± 0.01 0.02 ± 0.01 0.01 ± 0.02
0.00 ± 0.00 0.01 ± 0.01 0.01 ± 0.01
0.02 ± 0.01 0.02 ± 0.02 0.01 ± 0.01
0.00 ± 0.00 0.02 ± 0.02 0.02 ± 0.02
*p < 0.05 versus baseline in paired t test. Data are shown as mean values ± standard deviation. DTZ = diltiazem.
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most sensitive indicators are mitochondria and glycogen.
Margination and fragmentation of chromatin were seen in
the cells in which the mitochondria had electron-dense de-
Figure 2. Comparison of ischemic myocardial cellular damage in
five left ventricular wall layers from untreated hearts (open circles)
and from hearts pretreated with diltiazem (solid circles). I = a
thin layer immediately beneath endocardium; II = subendocardial
third except layer I; III = mid-myocardial third; IV = subepi-
cardial third except layer V; V = a thin layer immediately beneath
epicardium; B = border zone. no tissue evaluation. * = p <
0.05, chi-square analysis of grade distributions. All values rep-
resent five animals; grand means ± standard deviation of cellular
damage grade scores.
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posits. In this way. the light microscopic gade assignments
were evaluated and confirmed.
Statistical analysis. Temporal changes in hemodynamic
variables in each pig were evaluated using paired t test
analysis, comparing data obtained at each time point during
infusion with diltiazem and occlusion with baseline values
before infusion. Regional blood flow data were analyzed by
a two-way analysis of variance of occlusion versus respec-
tive baseline values and between different layers of the
myocardium at a fixed time. Histologically graded cell dam-
age comparisons between untreated and treated hearts were
evaluated with the chi-square test. All values of histologic
cell damage grades presented in the figures represent grand
mean ± standard deviation for the number of pigs in the
particular group. Statistical significance and rejection of the
null hypothesis was achieved when probability (p) was less
than 0.05 from the chi-square analysis.
Results
Blood concentration of diltiazem. Blood concentra-
tions of diltiazem were established only in the group with
40 minutes of occlusion. After 20 minutes of infusion and
immediately before coronary artery occlusion, the concen-
tration of diltiazem was 287 ± 78 ng/ml blood; by 40
minutes after occlusion this had decreased to 46 ± 12 ng/ml
blood.
Hemodynamic data. In all groups, diltiazem signifi-
cantly decreased heart rate, left ventricular systolic pressure
and aortic diastolic pressure from baseline levels (Table 2).
These variables returned toward baseline rapidly on ces-
sation of the infusion, but were still depressed after 10 and
20 minutes of occlusion. Aortic diastolic pressure remained
decreased during 40 minutes of occlusion in the treated
group. No significant changes in left ventricular end-
diastolic pressure were detected during infusion of diltiazem
or after coronary artery occlusion. There were no significant
differences during occlusion in heart rate, left ventricular
systolic pressure or aortic diastolic pressure between the
control group and those receiving diltiazem.
Regional blood flow. Regional myocardial blood flow
increased significantly in all layers during diltiazem infusion
(Table 3). Ligation of the distal anterior descending coro-
nary artery reduced flow to less than 0.05 ml/g per min in
all dependent samples of each heart in all groups.
Morphologic analysis. The transmural histologic find-
ings are quantitated for the five layers shown in Figure 2.
Changes after 20 minutes' occlusion. A transmural
gradient of ischemic cellular damage from layer II to layer
IV was present in both the untreated control group (2.3 ±
0.1 to 1.3 ± 0.2) and the diltiazem-treated group (1.2 ±
0.1 to 0.3 ± 0.1). The cellular damage was significantly
less transmurally in the treated group than in the untreated
control group (Fig. 2). In pigs receiving diltiazem, layers
IV and V showed near normal histologic features and min-
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imal changes in nuclear, perinuclear and "intermyofibril-
lar" substances (Fig. 3). A considerable amount of glycogen
was present in diltiazem-treated hearts (even in layer II)
compared with that in untreated hearts (Fig. 4A and B).
Changes after 40 minutes' occlusion. The ischemic
cellular damage, especially in layers II, 1lI and IV, was
intensifiedin both untreated and diltiazem-treated groups in
comparison with that in hearts subjected to 20 minutes of
ischemia. Layer II was most severely damaged and layers
I and V showed the least cellular damage (Fig. 2). A trans-
mural gradient of injury was present from layer II to layer
IV in both the untreated group (3.6 ± 0.1 to 1.9 ± 0.3)
and the diltiazem-treated group (2.5 ± 0.4 to 1.1 ± 0.2).
The hearts of pigs pretreated with diltiazem had signif-
icantly less damage in layers II through V than did hearts
from the untreated control group (Fig. 2). In layer II, marked
nuclear changes, considerable vacuolization and granulation
and mitochondrial edema with considerable amorphous den-
sities, which were seen in untreated hearts, Were not detected
in treated hearts (Fig. 4C and D, 5A and B). An increased
amount of glycogen remained transmurally in the treated
hearts in comparison with untreated control hearts (Fig. 4C
and D).
Changes after 120 minutes' occlusion. In layers II, 1lI
and IV, the ischemic cellular damage was severe and the
transmural gradient of cellular injury from layer II to layer
Figure 3. Light micrographs from heart after occlusion for 20
minutes. A, Layer IV from a diltiazem-treated heart. Most cells
have normal histologic features. Compact perinuclear and inter-
myofibrillar substance (arrow) and no clumping or margination
of chromatin are seen. B, Layer IV from an untreated control
heart. Minimal or mild clumping and margination of chromatin
and decreased staining of perinuclear and intermyofibrillar sub-
stance are detected. C, Layer II from a diltiazem-treated heart.
Most cells have typical cellular damage of grade I. Note minimal
clumping and margination of chromatin. The interior of nuclei
show opaque color, indicating mild dispersion of chromatin (ar-
row) compared with D. D, Layer II from an untreated control
heart. Most cells show the features of cell damage of grade 2, that
is, moderate clumping and margination of chromatin and markedly
decreased staining intensity of perinuclear and intermyofibrillar
substance are seen (toluidine blue stain, x 600). A through D
reduced by 20%.
IV was no longer present either in the untreated group (4.9
to 5.0 ± 0.1) or in the diitiazem-treated group (4.3 to 4.5
± 0.2). However, the drug-treated group exhibited signif-
icant but only slightly less myocardial damage. Although
increased granulation and vacuolization, marked edema and
frequent disruption of myofibrils at the Z band or intercalated
disc, or both, were rare in the treated hearts, the myocardial
cells did show numerous intramitochondrial amorphous den-
sities, an abnormally clear mitochondrial matrix and fewer
glycogen granules (Fig. 4E and F, 5C and D).
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In the endocardial (I) and epicardial (V) layers, cellular
damage was slight and there was no significant difference
in the mean cellular damage score between the groups. In
these layers, most cells had minimal changes in nuclear,
perinuclear and "intermyofibrillar" substance and consid-
erable glycogen and no intramitochondrial amorphous den-
sities (Fig. 6).
Discussion
Our data suggest that intravenous pretreatment with dil-
tiazem can retard the onset of ischemic cellular damage
subsequent to coronary artery ligation. This protective ac-
tion includes retardation of cellular damage in mural layers
Figure 4. Transmission electron mi-
crographs from layer 1\ of hearts after
various periods of occlusion. A, C and
E were taken from pretreated hearts
after occlusion of 20.40 and 120 min-
utes, respectively. B, 0 and F were
taken from untreated control hearts after
occlusion of 20.40 and 120 minutes.
respectively. Note progression of cel-
lular damage according to duration of
ischemia in both groups and less cel-
lular damage in pretreated hearts in
each of the periods of ischemia. In
pretreated hearts. nuclear (N) change
and edema are milder in each of the
periods of occlusion and considerable
glycogen (arrow, panels A and C) is
preserved after 20 and 40 minutes of
occlusion. Fewer amorphous densities
• in mitochondria (M) are noted in pre-
treated hearts after 40 minutes' occlu-
sion compared with those in untreated
control hearts (arrowhead, panel 0).
Disruption of myofibril at Z bands or
intercalated discs (arrow, panel F) is
rare in pretreated hearts and frequent
in untreated hearts, especially after oc-
clusion of 120 minutes. Arrow in panel
E indicates intercalated disc. Glyco-
gen (G, panel C) is well preserved
after 40 minutes' occlusion compared
with that in untreated control hearts
(panel 0) Bar indicates I M, panels
A, B, C, E and F reduced by 27%,
panel 0 reduced by 31 %.
II, III and IV during ischemic periods as long as 120 minutes
and an increased number of normal cells in epicardial and
endocardial layers (I and V) after 20 and 40 minutes of
ischemia when mild and presumably reversible cellular dam-
age exists.
Ischemia: coronary ftow in pig hearts. The coronary
circulation of the pig is generally believed to lack collateral
artery channels (18,24-27). However, it has been suggested
(24,25,28) that the thin layers immediately beneath the
endocardium and epicardium in the young pig may have a
very limited collateral flow after coronary artery occlusion.
In the present study, more normal cells were found in layers
I and V in hearts treated with diltiazem than in these same
regions in untreated hearts. Small vessels were sometimes
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noted in the center of penetrating peninsulas of normal cells
in these samples. Contraction bands, which are associated
with reflow after ischemia (29), were also seen in these
layers and may have been linked to enhanced perfusion in
the diltiazem-treated hearts. The radioactive microsphere
technique used in this study is not designed to quantitate
blood flow in tissue samples containing only 10 cell layers
(layers I and V). Therefore, we are unable to document the
precise perfusion of these regions by this method and relied
on the distribution of a vital dye and histologic character-
ization of cell morphology to evaluate the effect of dilti-
azem. Our observations indicate that the increased propor-
tion of normal cells in layers I and V in hearts treated with
diltiazem may be due to increased blood flow produced by
diltiazem. However, cellular damage was less in layers II,
III and IV where blood flow was less than 0.05 mllmin per
g tissue (below the level of resolution by the microsphere
method) and no vital dye penetrated to these layers. Thus,
•'protection" by diltiazem of cells in these regions appeared
to be independent of blood flow.
Although a few cell layers in epicardial and endocardial
surfaces are "preserved" by diltiazem, this should not be
expected to be reflected in beneficial myocardial mechanical
function. Myocardial regions have little flow reserve with
regard to mechanical performance. At intramyocardial blood
flows of less than 0.05 mllmin per g, as seen in this study,
there is no active myocardial contraction; in fact, aneurys-
mal bulging occurs during ventricular systole (18).
Figure 5. Light micrographs from layer II. A and B were taken
from pretreated and untreated control hearts, respectively, after
occlusion of 40 minutes, respectively. C and D were taken from
pretreated and untreated control hearts, respectively, after occlu-
sion of 120 minutes. Note progressive cellular damage in both
groups according to periods of ischemia and fewer cellular lesions
in pretreated hearts. Cells in A have mild to moderate nuclear
changes and ischemic grade of 2 and 3. Cells in B have vacuoli-
zation and focal granulation with marked nuclear changes and the
ischemic grade is 4. Histologic changes similar to B were seen in
C. In D, increased vacuolization, edema and granulation with
marked nuclear changes were seen. The ischemic grade is 5 (to-
luidine blue stain, x 600). A through D reduced by 20%.
Potential protective mechanisms of diitiazem. Our study
suggests that diltiazem given before coronary artery occlu-
sion is able to retard the progression of ischemic cellular
damage that occurs between 20 and 120 minutes after coro-
nary artery ligation in subendocardial (II), mid-myocardial
(III) and subepicardial (IV) layers of the pig heart. However,
diltiazem does not i1Ppear to substantially reduce the even-
tual irreversible cellular damage that occurs after 2 hours
of occlusion. We suggest that the "protective" cellular ef-
fects observed in intramural layers II, III and IV up to 40
minutes of ischemia do not depend on blood flow since
these layers had neither isotope nor dye penetration.
Hemodynamic factors appear to play little role in the
cellular protection afforded by diltiazem. Although heart
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Figure 6. Structural preservation of epicardial layer V after oc-
clusion for 120 minutes. A, light micrograph (toluidine blue stain,
x 600). D, transmission electron micrograph. Note the minimal
nuclear (N) changes and the considerable amount of glycogen
(arrow). The histologic sample was taken from a heart pretreated
with diltiazem (bar indicates I J.L). A and D reduced by 20%.
rate, left ventricular systolic and systemic diastolic pressures
decreased slightly during diltiazem infusion, they rapidly
returned to baseline values. There were no significant dif-
ferences in hemodynamic data between untreated control
and treated groups. The direct protective effect of diltiazem
on ischemic myocardial function in vivo has been previously
noted (6,14) and has been demonstrated to be independent
of hemodynamic factors in vitro (7). Our data support these
observations and suggest that the protective effect in layers
II, 1II and IV in pig hearts most probably is independent of
the cardiac or hemodynamic actions of diltiazem. It is pos-
sible that a direct action of diltiazem on cell membranes
and possibly on mitochondria of the ischemic myocardium
(6,7,30) may account for our findings. Similarly, we can
only postulate that the kinetics of diltiazem trapped in the
nonperfused ischemic region may be different from that in
perfused regions. If this were so, the cellular actions of
diltiazem (for example, ion movement inhibition and mem-
brane stabilization) would be expected to persist and become
expressed as reduced cellular damage during early periods
of myocardial ischemia.
In a previous study (16), we reported that a transmural
gradient of ischemic cellular damage in pig hearts from layer
II to layer IV appears after 20 and 40 minutes of coronary
occlusion and becomes severe and transmurally uniform
after 120 minutes of occlusion. This phenomenon is inde-
pendent of myocardial blood flow or its distribution in the
ischemic left ventricular wall and may result from a trans-
mural gradient of wall stress, tissue pressure or metabolism
although no measures of these factors have been made by
us. This flow-independent wavefront phenomenon (31) was
not removed in hearts pretreated with diltiazem.
The specific cellular and intracellular sites where dilti-
azem exerts its beneficial effects cannot be identified from
the findings of this study. However, the most important
changes appeared to be diminished cellular edema, pres-
ervation of glycogen and reduction in the development of
electron-dense bodies within the mitochondria. Although
the reduction of mitochondrial damage is not definite proof
of cell viability, this change is associated with lesser degree
of cell injury. The reduced number or lack of mitochondrial
deposits observed in the same cell may reflect a reduced
influx of extracellular calcium or a redistribution of intra-
cellular calcium or result from a direct effect on mitochon-
drial calcium transport systems (30). Diltiazem, in some
way, may also act to maintain structural integrity of the
sarcolemma. We recently reported (32) that the "calcium
paradox" was associated with injury to the junctional sar-
colemma, and this was prevented by diltiazem. We also
reported (33) that loss of high energy phosphates was re-
duced in the treated hearts after the calcium paradox. Thus,
the retention of adenosine triphosphate by diltiazem in the
ischemic myocardium (6), as indicated by reduced mito-
chondrial injury, may also ensure the adenosine triphos-
phate-dependent mechanisms of intracellular calcium bal-
ance (34). Therefore, it is likely that calcium-associated
changes and increased amounts of available glycogen may
contribute to the protective action of the drug seen in these
pig hearts.
Diltiazem dosages. The total diltiazem dose of 400 jLg/kg
(20 jLg/kg per min for 20 minutes, intravenously) was se-
lected because it produced an increase in coronary blood
flow in the pig heart without significant hypotension, myo-
cardial depression or atrioventricular conduction delay (5).
The concentration of diltiazem in the blood was 287 ng/ml
immediately before occlusion, and this decreased to 46 ng/rnl
at 40 minutes after occlusion. Heart rate, left ventricular
systolic pressure and end-diastolic pressure decreased slightly
and had recovered by 40 minutes of occlusion under anes-
thesia. In healthy human subjects, peak plasma concentra-
tions are 72, 117 and 152 ng/ml blood after oral adminis-
tration of 60, 90 and 120 mg/kg, respectively (17). The
usual oral doses of diltiazem are 120 to 360 mg/day (9-11).
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Therefore, the diltiazem blood concentrations achieved in
the present study are in the range found clinically. We
emphasize, however, that blood concentrations of this drug
and other clinically useful calcium channel blockers are
variable and of no documented value in determining ther-
apeutic efficacy.
Caution. We cannot assume from these studies that the
beneficial effects of diltiazem extend to other calcium an-
tagonists. Major differences among the three clinically re-
ferred drugs, nifedipine, verapamil and diltiazem, are cur-
rently becoming obvious (35). Profound qualitative differences
among these drugs at receptors or sites of binding recently
reported (36) may reveal insights into the complex mech-
anisms that are undoubtedly involved in protection of the
ischemic heart.
The animal preparations were made with the assistance of 10hn Erickson
and Victoria Rapien. Preparation of tissues for fixation, sectioning and
histology was done by 10hn Benedict. We gratefully recognize the Doc-
ument Processing Area of the Department of Pathology for typing this
manuscript. Diltiazem was supplied and the blood concentrations were
measured by Marion Laboratories, Kansas City, courtesy of Ronald K.
Browne, PhD.
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